Evaluation of Revised Classification Criteria for Giant Cell Arteritis and Its Clinical Phenotypes
Rheumatology (Oxford), 61:383-387, Wiberg,F.,et al, 2022
Vision Loss in Giant Cell Arteritis
Pract Neurol 22:138-140, Donaldson, L. & Margolin, E., 2022
FDG-PET/CT of Giant Cell Arteritis with Normal Inflammatory Markers
Ann Neurol 92:337-339, Koizumi, N.,et al, 2022
Progressive Vertebrobasilar Vasculopathy and Stroke Secondary to Giant Cell Arteritis
Stroke 53:e435-e438, Mahjoub, Y.,et al, 2022
An Unusual Cause of Stroke
BMJ 379:e066326, Day,J.&Lashley,D., 2022
Vessel Wall MR Imaging for the Detection of Intracranial Inflammatory Vasculopathies
Cardiovasc Diagn Ther 10:1108-1119, Edjlali,M.,et al, 2020
CT Analysis of the Aorta in Giant-Cell Arteritis: A Case-Control Study
Eur Radiol 28:3676-3684, Berthod, P.E.,et al, 2018
EULAR Recommendations for the Use of Imaging in Large Vessel Vasculitis in Clinical Practice
Ann Rheum Dis 77:636-643, Dejaco,C.,et al, 2018
Simultaneous Bilateral Posterior Ischemic Optic Neuropathy Secondary to Giant Cell Arteritis
BMC Ophthalmology 18:317, Albarrak, A.A.,et al, 2017
Successful Antiviral Treatment of Giant Cell Arteritis and Takayasu Arteritis
JAMA Neurol 72:943-946, Gliden D.,et al, 2015
Extra- and Intracranial Cerebral Vasculitis in Giant Cell Arteritis
Medicine doi:10.1097/MD.0000000000000265, Lariviere, D.,et al, 2014
A Sleeping Giant
NEJM 365:72-77, Morris, A.,et al, 2011